MITC is uniquely positioned to help investigators and partners turn scientific promise into practical progress. Located across the road from the University of Missouri Research Reactor, the center offers direct access to MURR radioisotopes and centralizes comprehensive resources for chemistry, radiochemistry, in vitro assays, in vivo imaging and translational research. Its radiochemistry laboratories include dedicated synthetic chemistry and radiochemistry space, analytical and quality-control instrumentation, and shared equipment that supports the development, evaluation and optimization of radiopharmaceuticals for imaging and therapy.

MITC’s imaging capabilities include PET/SPECT/CT and MRI resources that support research across disease models and stages of development. The center provides animal imaging and therapy capabilities for rodent, companion-animal and large-animal studies, along with connections to veterinary and human translational research infrastructure. This continuum helps investigators move discoveries from early radiotracer development and preclinical testing toward applications that may inform future clinical care.

What sets MITC apart is the alignment of specialized facilities with multidisciplinary faculty expertise across molecular imaging, radiochemistry, radiopharmacology, veterinary medicine, medicine, cancer research and translational science. For investigators, MITC offers shared infrastructure and expert collaboration that can strengthen research programs and open new directions for discovery. For industry partners, MITC provides a coordinated bridge to university expertise, radioisotope research, imaging technologies and translational capabilities. For patients and communities, MITC represents a commitment to advancing the next generation of diagnostic imaging and targeted therapeutic strategies. Importantly, MITC sits alongside an academic hospital where treatments can translate to the bedside with real time impact.